Summary of DIA Workshop: Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals
- 1 July 2010
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 44 (4) , 485-504
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Romiplostim in chronic immune thrombocytopenic purpuraClinical Therapeutics, 2009
- Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpuraEuropean Journal of Haematology, 2009
- Glycosylation profiling of a therapeutic recombinant monoclonal antibody with two N-linked glycosylation sites using liquid chromatography coupled to a hybrid quadrupole time-of-flight mass spectrometerAnalytical Biochemistry, 2008
- U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy RegimensClinical Cancer Research, 2008
- Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in miceBiologicals, 2008
- Recombinant clotting factorsThrombosis and Haemostasis, 2008
- FcRn: the neonatal Fc receptor comes of ageNature Reviews Immunology, 2007
- Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune DiseasesAnnual Review of Medicine, 2004
- Characterization of Monoclonal Antibody Glycosylation: Comparison of Expression Systems and Identification of Terminal α-Linked GalactoseAnalytical Biochemistry, 1997
- Getting the glycosylation right: Implications for the biotechnology industryNature Biotechnology, 1996